Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that its Annual Report and Accounts for the year ended 31 July 2018 and the Notice of the 2019 Annual General Meeting are now available on theis website.
Copies of the Annual Report and Accounts and the Notice of AGM have been posted to shareholders who have elected to receive them in paper form.
The Annual General Meeting will be held on Monday, 21 January 2019 at 2.00 p.m. at the offices of WG Partners LLP at 85 Gresham Street, London EC2V 7NQ. Shareholders who plan to attend are requested, if possible, to register their attendance by email to investorevents@avacta.com.